ArticleMediators of inflammation2026
Association Between Sleep and Cardiovascular-Kidney-Metabolic Syndrome: Mediation Analysis of Inflammatory Biomarkers.
Article in Mediators of inflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association Between Sleep and Cardiovascular-Kidney-Metabolic Syndrome: Mediation Analysis of Inflammatory Biomarkers.Mediators of inflammation · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
BACKGROUND AND
aimsSleep disturbances are linked to individual cardiometabolic diseases, but their association with the emerging cardiovascular-kidney-metabolic (CKM) syndrome, a constellation of interrelated conditions, remains less clear. To evaluate the association of sleep factors (sleep duration, diagnosed sleep disorder, self-reported trouble sleeping) with the risk of CKM syndrome. METHODS AND
resultsWe included 11,949 adults from the National Health and Nutrition Examination Survey (NHANES). A composite sleep score (0-3, from healthy to poor) was derived from sleep duration, diagnosed sleep disorder, and self-reported trouble sleeping. CKM syndrome was defined and staged (Stage 0-4) based on the coexistence and severity of cardiometabolic and kidney diseases. Systemic inflammation was assessed using the systemic immune-inflammation index (SII) and systemic inflammation response index (SIRI). A poor sleep pattern was significantly associated with higher odds of CKM syndrome (fully adjusted odds ratio [OR] = 1.64, 95% confidence interval (CI): 1.37-1.95) and with more advanced CKM stages in an ordinal model, indicating a dose-response relationship. In exploratory mediation analysis, SII and SIRI appeared to partially mediate the association between self-reported trouble sleeping and CKM syndrome in initial models. However, this mediating effect was substantially attenuated and became nonsignificant for SII after comprehensive adjustment for adiposity (body mass index (BMI) and waist circumference) and lifestyle factors.
conclusionsPoor sleep patterns are robustly associated with an increased risk and severity of CKM syndrome. While systemic inflammation was correlated with both sleep disturbances and CKM, its role as an independent mediator was largely explained by shared variance with obesity and metabolic factors. These findings underscore sleep health as a potential target for multimodal risk reduction within the CKM framework, though causality needs confirmation in longitudinal studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.